Pronova BioPharma ASA : Mandatory notification of trade

Pronova BioPharma ASA : Mandatory notification of trade

ID: 205706

(Thomson Reuters ONE) -


Notification of large trade/mandatory notification of trade

Reference is made to the announcement from Pronova BioPharma ASA ("Pronova")
today regarding the voluntary offer from BASF to acquire all the shares of
Pronova for NOK 12.50 per share (the "Offer").

Herkules Private Equity (Jersey-I) L.P. has on 20 November 2012 pre-accepted the
Offer for 126,378,281 shares, corresponding to 42.01% of the outstanding shares
in Pronova. The pre-acceptance represents the total holding of shares and rights
to shares held by Herkules Private Equity (Jersey-I) L.P. in Pronova. Following
a successful completion of the Offer Herkules Private Equity (Jersey-I) L.P.,
will not hold any shares in Pronova.

Herkules Private Equity (Jersey-II) L.P. has on 20 November 2012 pre-accepted
the Offer for 24,072,055 shares, corresponding to 8.00% of the outstanding
shares in Pronova. The pre-acceptance represents the total holding of shares and
rights to shares held by Herkules Private Equity (Jersey-II) L.P. in Pronova.
Following a successful completion of the Offer Herkules Private Equity (Jersey-
II) L.P., will not hold any shares in Pronova.

Herkules Private Equity (Jersey-I) L.P. and Herkules Private Equity (Jersey-II)
L.P. are represented at the board of directors of Pronova.


This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.



This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Pronova BioPharma ASA via Thomson Reuters ONE




[HUG#1659666]




Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  ABLYNX AND ALGETA ENTER INTO A RESEARCH COLLABORATION TO EVALUATE THE POTENTIAL OF NOVEL ALPHA-PHARMACEUTICALS COMPRISING THORIUM-277 CONJUGATED TO TUMOUR-TARGETING NANOBODIES Pronova BioPharma ASA : Mandatory notification of trade
Bereitgestellt von Benutzer: hugin
Datum: 21.11.2012 - 07:04 Uhr
Sprache: Deutsch
News-ID 205706
Anzahl Zeichen: 2120

contact information:
Town:

Lysaker



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 150 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Pronova BioPharma ASA : Mandatory notification of trade"
steht unter der journalistisch-redaktionellen Verantwortung von

Pronova BioPharma ASA (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

TAK-085 Entered into Phase 3 Clinical Programs ...

December 14, 2009, Osaka, Japan and Lysaker, Norway --- Takeda Pharmaceutical Company Limited (Osaka, Japan, "Takeda") and Pronova BioPharma ASA (OSE: PRON.OL) (Lysaker, Norway, "Pronova") today announced that the advancement of T ...

Financial calender 2010 for Pronova BioPharma ASA ...

FINANCIAL CALENDAR 2010 Pronova BioPharma ASA (PRON) Lysaker, 7 December 2009: 12 February 2010: FY 2009 Results 7 May 2010: Results 1Q 2010 7 May 2010: Annual General Meeting 13 August 2010: Results 2Q 2010 12 November 2010: Results 3Q 2010 Al ...

Alle Meldungen von Pronova BioPharma ASA



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z